Biotechnology Analysis & Statistics in the United States, September 2014

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: biotech, biomedical, protein, more »

1-30 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report provides detailed market, technology, and industry analyses to quantify and qualify the global market for prescription drug products. Important trends are identified and sales ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe, India, Canada, Germany, Japan, China, Brazil, Spain, Italy, France, Asia, Mexico, North America, United Kingdom
Induced Pluripotent Stem Cells : Global Markets

Induced Pluripotent Stem Cells : Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field ...

  • Industries : Biological Therapy
  • Countries : World, United States
US Next-generation Sequencing Market

US Next-generation Sequencing Market

  • $ 6 000
  • Industry report
  • June 2014
  • by Frost & Sullivan

Marketplace Evolves in Preparation for Clinical Sequencing Windfall The total market, as defined by this study, includes next-generation sequencing instruments and reagents in the United States. Instruments ...

  • Industries : Genomics
  • Countries : United States
Vaccine Partnering Terms and Agreements

Vaccine Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • July 2014
  • by Currentpartnering

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biopharmaceutical
  • Countries : United States
PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

  • $ 2 995
  • Industry report
  • June 2014
  • by Global Data

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market Summary GlobalData's report, "PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars ...

  • Industries : Biopharmaceutical
  • Countries : South Korea, India, World, China, United States, Japan, Asia, Europe
Analysis of the US Molecular Imaging Informatics Market

Analysis of the US Molecular Imaging Informatics Market

  • $ 2 500
  • Industry report
  • July 2014
  • by Frost & Sullivan

Growth Opportunities in Nuclear and PET Imaging Informatics Subsist Despite Downward Pressures on Equipment Markets This study provides an analysis of the US market for molecular imaging informatics solutions ...

  • Industries : Genomics
  • Countries : United States
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders - Overview

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders - Overview

  • $ 2 495
  • Industry report
  • July 2014
  • by CHI Insight Pharma Reports

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biomarkers ...

  • Industries : Genomics
  • Countries : United States
Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

  • $ 1 899
  • Industry report
  • August 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage ...

  • Industries : Biopharmaceutical
  • Countries : United States
Genomics Industry: Seattle Genetics, Inc. – Product Pipeline Review – Q4 2010

Genomics Industry: Seattle Genetics, Inc. – Product Pipeline Review – Q4 2010

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

- Product Pipeline Review - Q4 2010” provides a detailed overview on the firm ’s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Genomics
  • Countries : United States
Biotechnology Market in the United States

Biotechnology Market in the United States

  • $ 1 020
  • Industry report
  • June 2014
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's May Biotechnology in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry Risk Ratings report ...

  • Industries : Biopharmaceutical
  • Countries : United States
Seattle Genetics Partnering 2009-2014

Seattle Genetics Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Partnering Agreements with Seattle Genetics 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. This report ...

  • Industries : Genomics
  • Countries : United States
Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update

Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • July 2014
  • by Global Data

Summary Transgenomic, Inc. (Transgenomic) is a biotechnology company. The company offers medicine in cardiology, oncology, and inherited diseases through its molecular technologies. Its diagnostic tools ...

  • Industries : Genomics
  • Countries : United States
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based therapies to repair and rebuild diseased tissues and organs. It has developed a regenerative ...

  • Industries : Biological Therapy
  • Countries : United States
Physician Views: Are neurologists ready to embrace gene therapy?

Physician Views: Are neurologists ready to embrace gene therapy?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

Description As recently noted by Forbes, the biotech bull market of 2013 has helped to revive an approach to drug development that had become largely abandoned and pursued by only a few devoted believers. ...

  • Industries : Biological Therapy
  • Countries : United States
Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Genomics
  • Countries : United States
ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
American Biosystems, Inc. SWOT Analysis, Strategy, Revenues and Profits

American Biosystems, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
American Vietnamese Biotech Inc (Symbol:AMV) SWOT Analysis, Strategy, Revenues and Profits

American Vietnamese Biotech Inc (Symbol:AMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States, Vietnam
BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Eurofins Scientific SE (Symbol:ERF) SWOT Analysis, Strategy, Revenues and Profits

Eurofins Scientific SE (Symbol:ERF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States, World, Luxembourg
Helicos BioSciences Corporation (Symbol:HLCS) SWOT Analysis, Strategy, Revenues and Profits

Helicos BioSciences Corporation (Symbol:HLCS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States
Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

Kane Biotech Inc. (KNE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary Kane Biotech Inc. (Kane Biotech) is a biotechnology company. The company operates in research and development of products to prevent and disperse biofilms in medical and industrial applications. ...

  • Industries : Biotechnology
  • Countries : Canada, United States
QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

QuantRx Biomedical Corporation (Symbol:QTXB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Royalty Pharma SWOT Analysis, Strategy, Revenues and Profits

Royalty Pharma SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States, Ireland
Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

Verenium Corporation (Symbol:VRNM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Tiens Biotech Group (Symbol:USA) SWOT Analysis, Strategy, Revenues and Profits

Tiens Biotech Group (Symbol:USA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company operates in segments such as adult and pediatric market. It is a development stage regenerative ...

  • Industries : Biological Therapy
  • Countries : United States
AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary AdvanSource Biomaterials Corporation (AdvanSource) is a biomaterial manufacturing company. The company develops polymer based materials for the medical and pharmaceutical industries. Its products ...

  • Industries : Biomaterial
  • Countries : United States
American Oriental Bioengineering, Inc. (AOBI) - Financial and Strategic SWOT Analysis Review

American Oriental Bioengineering, Inc. (AOBI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • August 2014
  • by Global Data

Summary This comprehensive SWOT profile of American Oriental Bioengineering, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Biotechnology
  • Countries : United States
About 2 700 reports

Download Unlimited Documents from Trusted Public Sources

Vaccine Industry in the US

  • Human Papillomavirus Vaccination
  • August 2014
    36 pages
  • Vaccine  

    Cancer  

  • United States  

    North America  

View report >

16 Companies

Read our Company Profiles

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.